Title:
ＩＩ型糖尿病を処置するためのＧＰＲ１２０アゴニストとしてのイソチアゾール誘導体
Document Type and Number:
Japanese Patent JP6303031
Kind Code:
B2
Abstract:
Disclosed are compounds, compositions and methods for treating of disorders that are affected by the modulation of the GPRI20 receptor. Such compounds are represented by Formula (I) as follows: wherein R 1, G, and Q are defined herein.
Inventors:
Irig, Karl Earl.
Player, Mark Earl.
Jean, Shuchin
Player, Mark Earl.
Jean, Shuchin
Application Number:
JP2016573458A
Publication Date:
March 28, 2018
Filing Date:
March 07, 2014
Export Citation:
Assignee:
Janssen Pharmaceuticals N.B.
International Classes:
C07D275/02; A61K9/10; A61K31/425; A61K31/427; A61K31/4439; A61P3/00; A61P3/04; A61P3/06; A61P3/10; A61P5/50; A61P9/00; A61P19/10; C07D275/03; C07D417/04
Domestic Patent References:
| JP2012506386A | ||||
| JP200515461A |
Foreign References:
| WO2005094810A2 | ||||
| WO1999011255A1 |
Attorney, Agent or Firm:
Hiroshi Kobayashi
Eiji Katayama
Junko Kobayashi
Norio Omori
Hakoda Mitsuru
Yasuhito Suzuki
Eiji Katayama
Junko Kobayashi
Norio Omori
Hakoda Mitsuru
Yasuhito Suzuki
Previous Patent: Battery cooling structure of vehicles
Next Patent: OSCILLATION CIRCUIT AND PHASE LOCKED LOOP CIRCUIT
Next Patent: OSCILLATION CIRCUIT AND PHASE LOCKED LOOP CIRCUIT